The role of hepatic stellate cells and transforming growth factor-β1 in cystic fibrosis liver disease

American Journal of Pathology

Volumn 160, Issue 5, 2002, Pages 1705-1715

  Lewindon, Peter J ^a,b   Pereira, Tamara N ^b   Hoskins, Anita C ^b   Bridle, Kim R ^b   Williamson, Richard M ^c   Shepherd, Ross W ^d   Ramm, Grant A ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; MESSENGER RNA; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; BILE DUCT; BILE SECRETION; CELL ACTIVATION; CELL FUNCTION; CHILD; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS LIVER DISEASE; DISEASE ASSOCIATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCAR; STELLATE CELL;

EID: 0036095120     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61117-0     Document Type: Article

References (29)

1. Recommendations for management of liver and biliary tract disease in cystic fibrosis
2. Natural history of liver disease in cystic fibrosis
3. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells
4. Bile duct destruction and collagen deposition: A prominent ultrastructural feature of the liver in cystic fibrosis
5. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
6. Contribution of hepatic parenchymal cells and nonparenchymal cells to hepatic fibrogenesis in biliary atresia
7. Hepatic stellate cells
8. Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis
9. Hepatic stellate cell activation in genetic hemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
10. Fibrogenesis. V. TGF-beta signaling pathways
11. Classification of chronic viral hepatitis: A need for reassessment
12. Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease
13. Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype
14. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13
15. The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis
16. Cystic fibrosis in adults. An autopsy study
17. Expression of cystic fibrosis membrane conductance regulator in liver tissue from patients with cystic fibrosis
18. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration
19. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis
20. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
21. GUDC inhibits cytochrome c release from human cholangiocyte mitochondria
22. Liver disease and common-bileduct stenosis in cystic fibrosis
23. TGF-beta (1) genotype and accelerated decline in lung function of patients with cystic fibrosis
24. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells
25. Apoptosis in diseases of the liver
26. Apoptosis of hepatic stellate cells: Involvement in resolution of biliary fibrosis and regulation by soluble growth factors
27. Rat hepatic stellate cells contribute to the acute phase response with increased expression of alpha1 (I) and alpha (IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs
28. Connective tissue growth factor in human liver cirrhosis
29. Transforming growth factor-beta 1 in plasma and liver of children with liver disease